Literature DB >> 6615510

The ribonuclease inhibitors from porcine thyroid and liver are slow, tight-binding inhibitors of bovine pancreatic ribonuclease A.

P M Turner, K M Lerea, F J Kull.   

Abstract

Ribonuclease inhibitors were purified from the latent ribonuclease fractions of porcine thyroid and liver and used to test the hypothesis that their inhibition of bovine pancreatic ribonuclease A is correctly described by tight-binding rather than Michaelis-Menton kinetics. Both proteins were found to act as slow, tight-binding inhibitors of the enzyme. These steady-state velocities also showed that both the thyroid and liver inhibitors were competitive inhibitors of bovine pancreatic ribonuclease A with Ki's of 0.1 and 0.4 nM, respectively. In contrast to interpretations based on Michaelis-Menton assumptions that show non-competitive inhibition, these results suggest that an enzyme:inhibitor:substrate complex does not exist.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615510     DOI: 10.1016/0006-291x(83)90683-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

Authors:  B S Murthy; R Sirdeshmukh
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

2.  Theoretical treatment of tight-binding inhibition of an enzyme. Ribonuclease inhibitor as special case.

Authors:  J M Fominaya; J M García-Segura; M Ferreras; J G Gavilanes
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

3.  Kinetic Modeling of Time-Dependent Enzyme Inhibition by Pre-Steady-State Analysis of Progress Curves: The Case Study of the Anti-Alzheimer's Drug Galantamine.

Authors:  Doriano Lamba; Alessandro Pesaresi
Journal:  Int J Mol Sci       Date:  2022-05-03       Impact factor: 6.208

4.  Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.

Authors:  R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.